LATEST NEWS
UPCOMING EVENTS
FEATURED JOBS
JOIN THE CONVERSATION
-
SCOTUS Rules Against Amgen in PCSK9 Patent Dispute with Sanofi, Regeneron https://t.co/3UkUGI0Nzt https://t.co/JZZaIDyjbL
-
AstraZeneca Deepens Gene Editing Capabilities with Revvity Partnership https://t.co/qLF3qCYhK8 https://t.co/WnrjjRiKN4
-
US Appeals Court Panel Questions FDA Due Diligence on Abortion Pill https://t.co/fFUAJHkv9g https://t.co/9dhQdZ0zvk
-
FDA Shows Confidence in Pfizer’s Maternal RSV Shot Ahead of Panel https://t.co/bppByno2tm https://t.co/biZaEpV6Lx
-
New patent expiration for Fresenius Kabi drug NAROPIN https://t.co/IBtTBCUCNU
CTC PORTFOLIO TRACKER
XBI tracks an equal-weighted index of US biotechnology stocks.
ARKG is an actively managed fund that targets companies involved in the genomics industry.
ABOUT BIOCALIFORNIA
BioCalifornia is a coalition of innovators, investors, and industry leaders gathered under the auspices of the California Technology Council. Its members are committed to the growth of life sciences, and commercialization of discoveries to improve human health, the environment, and sustainability; and capitalizing on the convergence of biology with information technology. BioCalifornia works with its members to explore topics on the frontiers of innovation, creates opportunities for business development and investment, and showcases the expertise resident both within its members and other CTC special interest groups, such as CalCISO, Clean Acres, and the California Business Incubation Alliance.